[非外科センターにおけるTAVI:臨床的実用主義と規制上の課題のバランス]
1Hôpital Louis Pasteur, 4 rue Claude Bernard, 28630 Le Coudray, France.
まとめ
トランスキャセータ性大動脈弁移植 (TAVI) はリスクが低い患者に安全ですが,フランスの規則では心臓外科センターに義務付けられています. 患者の安全を損なうことなく 患者さんへのアクセスを改善し 待ち時間を短縮できます
科学分野:
- 心臓病科
- 介入心臓科
- 医療政策
さらに関連する動画
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10.7K
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.8K
関連する概念動画
Aortic Regurgitation III: Medical Management
42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
